|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-4-4
|
|
pubmed:abstractText |
Methylxanthines, including theophylline, have been used extensively and successfully to treat apnoea in preterm infants. However, long-term consequences of such therapy are largely unknown. The aim of this study was to determine the relationship between theophylline therapy and outcome at 14 years of age in surviving preterm children of birthweight < 1501 g.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1034-4810
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
47-50
|
|
pubmed:dateRevised |
2007-9-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10723691-Adolescent,
pubmed-meshheading:10723691-Apnea,
pubmed-meshheading:10723691-Bronchodilator Agents,
pubmed-meshheading:10723691-Cerebral Palsy,
pubmed-meshheading:10723691-Child Development,
pubmed-meshheading:10723691-Developmental Disabilities,
pubmed-meshheading:10723691-Female,
pubmed-meshheading:10723691-Follow-Up Studies,
pubmed-meshheading:10723691-Humans,
pubmed-meshheading:10723691-Infant, Newborn,
pubmed-meshheading:10723691-Infant, Premature,
pubmed-meshheading:10723691-Infant, Premature, Diseases,
pubmed-meshheading:10723691-Infant, Very Low Birth Weight,
pubmed-meshheading:10723691-Male,
pubmed-meshheading:10723691-Psychological Tests,
pubmed-meshheading:10723691-Survivors,
pubmed-meshheading:10723691-Theophylline
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, University of Melbourne, Australia. p.davis@obgyn-rwh.unimelb.edu.au
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
